GeoVax Labs, Inc.
News
GeoVax to Participate in Upcoming Investor Conferences in September
Globe Newswire ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...\n more…
GeoVax Labs Accelerates Capital Raise with Multiple Offerings
TipRanks Financial Blog The latest update is out from GeoVax Labs (GOVX). GeoVax Labs, Inc. launched a registered direct offering, selling over 837,000 shares and pre-funded warrants to pu...\n more…
GeoVax Labs to raise $5M via private placement
SeekingAlpha.com: All News GeoVax Labs (GOVX) raises $5M in a direct offering with an institutional investor, issuing shares at $5.125 each and warrants at an exercise price of $5.\n more…
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
Globe Newswire ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...\n more…
Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross?
Zacks Investment Research After reaching an important support level, GeoVax Labs Inc. (GOVX) could be a good stock pick from a technical perspective. GOVX recently experienced a "golden cross" event, which saw its 50-day...\n more…
